Skip to main content
. 2021 Mar;22(3):919–925. doi: 10.31557/APJCP.2021.22.3.919

Table 4.

Comparison of Aberrant Myeloid Antigen Expression and CD34 Expression in ALL in Literature

Serial
number
Ethnicity Age group (years) Number of patients MyAg studied Correlation between MyAg and CD34 p-value*
1. Mi et al (1999) Chinese Adult 102 NA Not found in ALL and B-ALL NA
2. Yeneral et al (2002) Turkish Adult
(14-62)
46 CD13, CD33 Not found in ALL 0.06
3. Vitale et al (2007) European (Rome) Adult
(14-60)
377 CD13, CD33 Present between MyAg+ and CD34+ in ALL <0.0001*
4. Tong et al (2010) Chinese All
(1-72)
113 CD13, CD33, CD15, CD117 Present between MyAg+ and CD34+ in ALL 0.002*
5. Tong et al (2011) Chinese Pediatric (0-14) 207 CD13, CD33, CD15, CD117 Present between MyAg+ and CD34+ in ALL 0.004*
6. Tong et al (2014) Chinese Adult
(15-77)
110 CD13, CD33, CD15, CD117 Present between MyAg+ and CD34+ in ALL 0.019*
7. Sharma et al (2014) Indian All
(2-61)
ALL (204) B-ALL (163) CD13, CD33, CD117 Present between MyAg+ and CD34high in ALL and B-ALL 0.0001* (in both ALL and B-ALL)
8. Sharma et al (2016) Indian All
(<1-65)
Adult (96), Pediatric (207) CD13, CD33, CD117 Present between MyAg+ and CD34+ in ALL p=0.001* (Adult), p=0.0004*
(Pediatric)
9. Present study (2020) Indian All 75 CD13, CD33 Not found in B-ALL 0.051

NA, Not available; My, Myeloid antigen expression; My+, Myeloid antigen positivity; ALL, Acute lymphoblastic leukemia; B-ALL, B- acute lymphoblastic leukemia; *p<0.05 is statistically significant